lifestyle.newsblaze.com

Author: MyOme, Inc

MyOme Demonstrates Clinical Validity of Integrated Polygenic and Clinical Risk Prediction for Coronary Artery Disease

March 20, 2026
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026

March 12, 2026
Thatch and MyOme Launch First Genomics Solution in Thatch’s Personalized Benefits Marketplace

December 15, 2025
/C O R R E C T I O N — MyOme, Inc/

December 14, 2025
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

December 12, 2025
MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics

December 4, 2025
MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention

November 22, 2025
MyOme Launches Proactive Health Network — A First-of-Its-Kind National Platform for Concierge & Executive Health Clinics Powered by Whole-Genome Precision

November 14, 2025
/R E I S S U E — MyOme, Inc/

November 14, 2025